[Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects].
D003864:Depression, Chemical; D004176:Dipyridamole / Q000097:blood / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010793:Phthalazines / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects*; D011724:Pyridazines / Q000494:pharmacology*; D011804:Quinolines / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D015363:Quinolones; D013442:Sulfinpyrazone / Q000097:blood / Q000494:pharmacology; D013927:Thrombosis / Q000188:drug therapy*
D010793:Phthalazines; D011724:Pyridazines; D011804:Quinolines; D015363:Quinolones; C021294:cilostamide; C011329:phthalazinol; D004176:Dipyridamole; D013442:Sulfinpyrazone